iSpecimen (NASDAQ:ISPC) Posts Quarterly Earnings Results

iSpecimen (NASDAQ:ISPC) released its earnings results on Wednesday. The company reported ($0.74) earnings per share for the quarter, FiscalAI reports. iSpecimen had a negative return on equity of 531.78% and a negative net margin of 343.86%.The firm had revenue of $0.05 million for the quarter.

iSpecimen Stock Performance

Shares of ISPC stock opened at $0.14 on Friday. The firm’s 50 day moving average price is $0.26 and its two-hundred day moving average price is $0.54. iSpecimen has a 52-week low of $0.14 and a 52-week high of $3.18. The stock has a market cap of $1.39 million, a PE ratio of -0.06 and a beta of 1.98.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iSpecimen stock. Virtu Financial LLC acquired a new position in shares of iSpecimen Inc. (NASDAQ:ISPC) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 63,257 shares of the company’s stock, valued at approximately $82,000. Virtu Financial LLC owned 0.65% of iSpecimen as of its most recent SEC filing. 13.62% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of iSpecimen in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

About iSpecimen

iSpecimen, Inc (NASDAQ:ISPC) operates an online life sciences marketplace designed to connect researchers with human biological specimens and associated clinical data. The company’s platform streamlines the sourcing of biospecimens—such as plasma, serum, fresh and frozen tissue, saliva, urine and peripheral blood mononuclear cells (PBMCs)—by matching demand from pharmaceutical, biotechnology, diagnostic and academic organizations with supply from a wide network of clinical sites and biobanks.

Through its on-demand procurement model, iSpecimen provides customized specimen collection and fulfillment services that help accelerate research timelines and improve data quality.